Bisoprolol Fumarate and Hydrochlorothiazide Tablets recall: Impurity Out of Spec
Bisoprolol Fumarate and Hydrochlorothiazide Tablets, USP, 5mg/6.25mg, 100-count Bottle, RX only, Manufactured by: Glenmark Pharmaceuticals Limited…
Why was Bisoprolol Fumarate and Hydrochlorothiazide Tablets recalled?
Failed Impurities/Degradation Specifications
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot# 17212352, Exp 11/31/2023
- Product
- Bisoprolol Fumarate and Hydrochlorothiazide Tablets, USP, 5mg/6.25mg, 100-count Bottle, RX only, Manufactured by: Glenmark Pharmaceuticals Limited…
- Recalling firm
- Glenmark Pharmaceuticals Inc., USA
- Quantity
- 480 100-count bottles
- Distribution
- Nationwide in the USA
- Recall date
- November 8, 2023
- Classification
- Class III
- Status
- Terminated
- Agency
- FDA (drug)